
Annual report 2022
added 12-21-2024
Genetron Holdings Limited Market Cap 2011-2026 | GTH
As of February 22, 2026 Genetron Holdings Limited has a market cap of $ 80.1 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.54 B | 1.66 B | 250 M | 60.1 M | 116 M | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.66 B | 60.1 M | 727 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M | ||
|
Trinity Biotech plc
TRIB
|
120 M | $ 0.73 | -1.86 % | $ 61.9 M | ||
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 29.0 | -3.07 % | $ 316 M | ||
|
Brainsway Ltd.
BWAY
|
240 M | $ 23.87 | -0.13 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
3.55 M | $ 1.14 | -2.16 % | $ 1.45 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M | ||
|
Celcuity
CELC
|
399 M | $ 104.95 | -1.72 % | $ 4.14 B | ||
|
Co-Diagnostics
CODX
|
34.9 M | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
152 B | $ 210.56 | -0.33 % | $ 154 B | ||
|
Castle Biosciences
CSTL
|
709 M | $ 29.41 | -6.17 % | $ 817 M | ||
|
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 B | $ 202.21 | -0.11 % | $ 22.4 B | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
25.5 B | $ 73.08 | 1.11 % | $ 28.5 B | ||
|
DarioHealth Corp.
DRIO
|
43.4 M | $ 11.75 | 2.8 % | $ 333 M | ||
|
CareDx, Inc
CDNA
|
521 M | $ 18.83 | -5.23 % | $ 1.01 B | ||
|
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | ||
|
Illumina
ILMN
|
16.4 B | $ 117.53 | -2.06 % | $ 18.7 B | ||
|
Fulgent Genetics
FLGT
|
467 M | $ 23.18 | -0.39 % | $ 701 M | ||
|
Exact Sciences Corporation
EXAS
|
19.5 B | $ 103.45 | 0.15 % | $ 19.5 B | ||
|
Lantheus Holdings
LNTH
|
6.47 B | $ 74.31 | 1.54 % | $ 5.14 B | ||
|
Guardant Health
GH
|
13.4 B | $ 103.36 | -2.84 % | $ 13 B | ||
|
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
16.6 B | $ 99.61 | 1.22 % | $ 8.22 B | ||
|
Interpace Biosciences
IDXG
|
4.12 M | $ 1.85 | 2.78 % | $ 8.12 M | ||
|
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
7.69 B | $ 169.68 | 3.11 % | $ 8.41 B | ||
|
IDEXX Laboratories
IDXX
|
37.7 B | $ 635.6 | 0.77 % | $ 52.4 B | ||
|
IQVIA Holdings
IQV
|
28.3 B | $ 166.19 | -1.87 % | $ 28.6 B | ||
|
Koninklijke Philips N.V.
PHG
|
30.8 B | $ 31.19 | 0.73 % | $ 20 B | ||
|
Biodesix
BDSX
|
92.1 M | $ 13.26 | 4.0 % | $ 1.72 B | ||
|
Quidel Corporation
QDEL
|
10.6 B | $ 22.47 | -4.85 % | $ 947 M | ||
|
Laboratory Corporation of America Holdings
LH
|
21.1 B | $ 283.38 | 0.32 % | $ 23.8 B | ||
|
Biomerica
BMRA
|
7.19 M | $ 2.17 | -2.25 % | $ 4.98 M | ||
|
Bioventus
BVS
|
351 M | $ 8.57 | -0.06 % | $ 537 M | ||
|
Medpace Holdings
MEDP
|
13 B | $ 452.99 | 1.47 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | ||
|
National Research Corporation
NRC
|
1.01 B | $ 13.65 | 9.64 % | $ 335 M | ||
|
Mettler-Toledo International
MTD
|
28.4 B | $ 1 378.44 | 0.14 % | $ 28.4 B |